Viewing Study NCT04979468


Ignite Creation Date: 2025-12-24 @ 5:52 PM
Ignite Modification Date: 2025-12-27 @ 6:00 AM
Study NCT ID: NCT04979468
Status: UNKNOWN
Last Update Posted: 2021-07-28
First Post: 2021-07-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Early DOlutegravir/LAmivudine Switching After Virological Suppression (EDOLAS Study)
Sponsor: Societa' Italiana Di Malattie Infettive E Tropicali
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module